Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary Disease

BackgroundThe family of Suppressor of Cytokine Signaling (SOCS) acts as a controller of the duration and intensity of cytokine function by negatively regulating the JAK-STAT signaling pathway. SOCS’ role in inflammatory diseases in animal models is well demonstrated. However, its role in the develop...

Full description

Bibliographic Details
Main Authors: Mariaenrica Tinè, Elisabetta Balestro, Sara Carpi, Tommaso Neri, Davide Biondini, Maria Conti, Alvise Casara, Nicol Bernardinello, Elisabetta Cocconcelli, Graziella Turato, Simonetta Baraldo, Alessandro Celi, Paolo Spagnolo, Manuel G. Cosio, Marina Saetta, Erica Bazzan
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1320077/full
_version_ 1797265547949244416
author Mariaenrica Tinè
Elisabetta Balestro
Sara Carpi
Sara Carpi
Tommaso Neri
Davide Biondini
Davide Biondini
Maria Conti
Alvise Casara
Nicol Bernardinello
Elisabetta Cocconcelli
Graziella Turato
Simonetta Baraldo
Alessandro Celi
Paolo Spagnolo
Manuel G. Cosio
Manuel G. Cosio
Marina Saetta
Erica Bazzan
author_facet Mariaenrica Tinè
Elisabetta Balestro
Sara Carpi
Sara Carpi
Tommaso Neri
Davide Biondini
Davide Biondini
Maria Conti
Alvise Casara
Nicol Bernardinello
Elisabetta Cocconcelli
Graziella Turato
Simonetta Baraldo
Alessandro Celi
Paolo Spagnolo
Manuel G. Cosio
Manuel G. Cosio
Marina Saetta
Erica Bazzan
author_sort Mariaenrica Tinè
collection DOAJ
description BackgroundThe family of Suppressor of Cytokine Signaling (SOCS) acts as a controller of the duration and intensity of cytokine function by negatively regulating the JAK-STAT signaling pathway. SOCS’ role in inflammatory diseases in animal models is well demonstrated. However, its role in the development of human disease is still under investigation. SOCS3 plays an important role in tumor development where its downregulation has been implicated in the pathogenesis of various solid tumors such as triple-negative breast cancer.AimThe aim of this work was to study (1) the expression of SOCS3 in smokers’ lungs and its relation to the degree of inflammation and (2) SOCS3 regulation by microRNA (miRNA) in alveolar-macrophage (AM)-derived extracellular vesicles (EVs) in bronchoalveolar lavage (BAL).MethodsGroup A: 35 smokers’ [19 with COPD (SC) and 16 without COPD (S)] and 9 nonsmokers (NS); SOCS3, TNFα in AM, and CD8+ T cells were quantified by immunohistochemistry, in lung tissue. Group B: additional 9 SC, 11 S, and 5 NS; AM-EVs expressing SOCS3 (CD14+SOCS3+) and SOCS3 suppressors miRNA-19a-3p and 221-3p in EVs were quantified by flow cytometry and PCR, in BAL.ResultsThe percentage of SOCS3+ AM was higher in SC [68 (6.6–99)%] and S [48 (8–100)%] than in NS [9.6 (1.9–61)%; p = 0.002; p = 0.03] and correlated with % of TNFα+AM (r = 0.48; p = 0.0009) and CD8+ T cells (r = 0.44; p = 0.0029). In BAL, the CD14+SOCS3+ EVs/μL were increased in SC [33 (21–74)] compared to S [16 (8–37); p = 0.03] and NS [9 (7–21); p = 0.003]. Conversely, miRNA-19a-3p and miRNA-221-3p expression were increased in S when compared to SC [19 (2–53) vs. 3 (0.6–8); p = 0.03 and 3 (0.005–9.6) vs. 0.2 (0.08–0.7); p = 0.05].ConclusionsThe suppressor function of SOCS3 in COPD seems to be overridden by other factors and does not follow the animal-model paradigm. Expression of SOCS3 in BAL macrophage-derived EVs might be useful to assess the degree of inflammation and possible progression of COPD. Downregulation of SOCS3, by miRNA, in smokers without COPD might contribute to the risk of developing cancer in these patients.
first_indexed 2024-04-25T00:46:32Z
format Article
id doaj.art-95720d0107b34876be93c27775dc8c75
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-25T00:46:32Z
publishDate 2024-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-95720d0107b34876be93c27775dc8c752024-03-12T04:35:38ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-03-011510.3389/fimmu.2024.13200771320077Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary DiseaseMariaenrica Tinè0Elisabetta Balestro1Sara Carpi2Sara Carpi3Tommaso Neri4Davide Biondini5Davide Biondini6Maria Conti7Alvise Casara8Nicol Bernardinello9Elisabetta Cocconcelli10Graziella Turato11Simonetta Baraldo12Alessandro Celi13Paolo Spagnolo14Manuel G. Cosio15Manuel G. Cosio16Marina Saetta17Erica Bazzan18Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, ItalyDepartment of Health Sciences, University ‘Magna Græcia’ of Catanzaro, Catanzaro, ItalyNational Enterprise for NanoScience and NanoTechnology (NEST), Istituto Nanoscienze-Centro Nazionale Ricerche (CNR) and Scuola Normale Superiore, Pisa, ItalyCentro Dipartimentale di Biologia Cellulare Cardiorespiratoria, Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell’Area Critica, Università degli Studi di Pisa, Pisa, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, ItalyDepartment of Medicine, University of Padova, Padova, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, ItalyCentro Dipartimentale di Biologia Cellulare Cardiorespiratoria, Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell’Area Critica, Università degli Studi di Pisa, Pisa, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, ItalyMeakins-Christie Laboratories, Respiratory Division, McGill University, Montreal, QC, CanadaDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, ItalyDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, ItalyBackgroundThe family of Suppressor of Cytokine Signaling (SOCS) acts as a controller of the duration and intensity of cytokine function by negatively regulating the JAK-STAT signaling pathway. SOCS’ role in inflammatory diseases in animal models is well demonstrated. However, its role in the development of human disease is still under investigation. SOCS3 plays an important role in tumor development where its downregulation has been implicated in the pathogenesis of various solid tumors such as triple-negative breast cancer.AimThe aim of this work was to study (1) the expression of SOCS3 in smokers’ lungs and its relation to the degree of inflammation and (2) SOCS3 regulation by microRNA (miRNA) in alveolar-macrophage (AM)-derived extracellular vesicles (EVs) in bronchoalveolar lavage (BAL).MethodsGroup A: 35 smokers’ [19 with COPD (SC) and 16 without COPD (S)] and 9 nonsmokers (NS); SOCS3, TNFα in AM, and CD8+ T cells were quantified by immunohistochemistry, in lung tissue. Group B: additional 9 SC, 11 S, and 5 NS; AM-EVs expressing SOCS3 (CD14+SOCS3+) and SOCS3 suppressors miRNA-19a-3p and 221-3p in EVs were quantified by flow cytometry and PCR, in BAL.ResultsThe percentage of SOCS3+ AM was higher in SC [68 (6.6–99)%] and S [48 (8–100)%] than in NS [9.6 (1.9–61)%; p = 0.002; p = 0.03] and correlated with % of TNFα+AM (r = 0.48; p = 0.0009) and CD8+ T cells (r = 0.44; p = 0.0029). In BAL, the CD14+SOCS3+ EVs/μL were increased in SC [33 (21–74)] compared to S [16 (8–37); p = 0.03] and NS [9 (7–21); p = 0.003]. Conversely, miRNA-19a-3p and miRNA-221-3p expression were increased in S when compared to SC [19 (2–53) vs. 3 (0.6–8); p = 0.03 and 3 (0.005–9.6) vs. 0.2 (0.08–0.7); p = 0.05].ConclusionsThe suppressor function of SOCS3 in COPD seems to be overridden by other factors and does not follow the animal-model paradigm. Expression of SOCS3 in BAL macrophage-derived EVs might be useful to assess the degree of inflammation and possible progression of COPD. Downregulation of SOCS3, by miRNA, in smokers without COPD might contribute to the risk of developing cancer in these patients.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1320077/fullsocs3extracellular vesiclesCOPDmiRNAhuman BALalveolar macrophages
spellingShingle Mariaenrica Tinè
Elisabetta Balestro
Sara Carpi
Sara Carpi
Tommaso Neri
Davide Biondini
Davide Biondini
Maria Conti
Alvise Casara
Nicol Bernardinello
Elisabetta Cocconcelli
Graziella Turato
Simonetta Baraldo
Alessandro Celi
Paolo Spagnolo
Manuel G. Cosio
Manuel G. Cosio
Marina Saetta
Erica Bazzan
Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary Disease
Frontiers in Immunology
socs3
extracellular vesicles
COPD
miRNA
human BAL
alveolar macrophages
title Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary Disease
title_full Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary Disease
title_fullStr Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary Disease
title_full_unstemmed Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary Disease
title_short Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary Disease
title_sort suppressor of cytokine signaling 3 expression and its regulation in relation to inflammation in chronic obstructive pulmonary disease
topic socs3
extracellular vesicles
COPD
miRNA
human BAL
alveolar macrophages
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1320077/full
work_keys_str_mv AT mariaenricatine suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT elisabettabalestro suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT saracarpi suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT saracarpi suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT tommasoneri suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT davidebiondini suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT davidebiondini suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT mariaconti suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT alvisecasara suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT nicolbernardinello suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT elisabettacocconcelli suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT graziellaturato suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT simonettabaraldo suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT alessandroceli suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT paolospagnolo suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT manuelgcosio suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT manuelgcosio suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT marinasaetta suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease
AT ericabazzan suppressorofcytokinesignaling3expressionanditsregulationinrelationtoinflammationinchronicobstructivepulmonarydisease